首页|幽门螺杆菌阴性胃黏膜相关淋巴组织淋巴瘤的研究进展

幽门螺杆菌阴性胃黏膜相关淋巴组织淋巴瘤的研究进展

扫码查看
随着医疗技术的发展,越来越多的证据表明,胃黏膜相关淋巴组织(MALT)淋巴瘤的发生与幽门螺杆菌(Hp)的感染密切相关.通过单纯根除Hp治疗已成为该疾病的一线治疗方案.但目前发现,还有绝大部分胃MALT淋巴瘤患者不存在Hp感染,Hp阴性的胃MALT淋巴瘤的发病机制、内镜临床表现和治疗方式与阳性患者存在不同.且治疗方案存在争议.本文总结了Hp为阴性的胃MALT淋巴瘤的发病机制、临床表现及治疗方案,并对未来治疗进行展望,为提高该疾病的治愈率以及降低不良反应发生率提供参考.
Research progress of Helicobacter pylori negative gastric mucosa-associated lymphoid tissue lymphoma
With the development of medical technology,more and more evidence shows that the occurrence of gastric mucosa-associated lymphoid tissue(MALT)lymphoma is closely related to the infection of Helicobacter pylori(Hp).Treatment by simple eradication of Hp has become the first-line treatment for the disease.However,it has been found that most patients with gastric MALT lymphoma do not have Hp infection,and the pathogenesis,endoscopic clinical manifestations and treatment methods of HP-negative gastric MALT lymphoma are different from those of positive patients.And treatment options are controversial.In this paper,the pathogenesis,clinical manifestations and treatment of HP-negative gastric MALT lymphoma are summarized,and the future treatment is prospected,so as to provide reference for improving the cure rate of this disease and reducing the incidence of adverse reactions.

Gastric mucosa-associated lymphoid tissue lymphomaHelicobacter pyloriPathogenesisDiagnosis and treatmentPrognosis

安亚楠、王端然、郭甜甜、武希润

展开 >

030001 太原,山西医科大学第二临床医学院

胃黏膜相关淋巴组织淋巴瘤 螺杆菌,幽门 发病机制 诊断与治疗 预后

2024

中华消化病与影像杂志(电子版)
中华医学会

中华消化病与影像杂志(电子版)

CSTPCD
影响因子:0.641
ISSN:2095-2015
年,卷(期):2024.14(3)
  • 3